Tuesday, November 22, 2016

Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients

 

by Colin R. Lenihan, Sumi Sukumaran Nair, Chandan Vangala, Venkat Ramanathan, Maria E. Montez-Rath, Wolfgang C. Winkelmayer
Posttransplantation bone disease is a significant problem, with few well-evidenced therapeutic options. Proton pump inhibitors (PPIs) are associated with hip fracture in the general population and are widely prescribed for kidney transplant recipients.
--

Shared via Inoreader



Enviado desde mi iPad

No comments:

Post a Comment